Harrow Stock

Harrow EPS

The Earnings per Share (EPS) of Harrow (HROW) as of Aug 10, 2026 is -0.14 USD. In the previous year, Earnings per Share (EPS) was -0.49 USD — a change of -71.36% (higher).

EPS

-0.14USD

YoY

-71.36%

Last updated:

Earnings per Share (EPS) of Harrow is 2026 -0.14 USD. Earnings per Share (EPS) of Harrow was 2025 -0.49 USD. It decreases by -71.36% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Earnings per Share (EPS) of Harrow is -0.14 USD in 2026.

Earnings per Share (EPS) of Harrow changed from -0.49 USD to -0.14 USD, representing a -71.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Harrow since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Harrow

All Key Metrics — Harrow